Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Fluicell AB
5J9Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet. The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden. Address: Flöjelbergsgatan 8C, Mölndal, Sweden, 431 37
Analytics
WallStreetin tavoitehinta
–P/E-suhde
0.359Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 5J9
Osinkoanalytiikka 5J9
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
–Osinkohistoria 5J9
Osakkeen arvostus 5J9
Talousasiat 5J9
Tuloksia | 2019 | Dynamiikka |